The crude and adjusted ORs for the MUTYH His/His genotype compare

The crude and adjusted ORs for the MUTYH His/His genotype compared with Gln/Gln genotype BI 2536 mw showed a increased risk for lung cancer (crude odds ratio [OR] 3.25, 95% confidence interval [95%CI] 1.44–7.36, p = 0.005; adjusted OR 3.03, 95%CI 1.31–7.00, p = 0.010, respectively), whereas there was no significant increase for the Gln/His genotype (crude OR 1.39, 95%CI 0.74–2.62, p = 0.309; adjusted OR 1.35,

95%CI 0.70–2.61, p = 0.376, respectively). Table 2 Genotype distribution in lung cancer and Allele frequency                       Allele frequency Genotype   patients (n = 108) controls (n = 121) crude   adjusted     patients controls     n % n % OR (95%CI) P-value OR (95%CI)a P-value   % % OGG1                           Ser/Ser 27 25.0 39 32.2 1.00   1.00   Ser 0.505 0.546   Ser/Cys 55 50.9 54 44.6 1.47 (0.79–2.73) 0.221 1.52 (0.80–2.91) EX527 0.204 Cys 0.495 0.455   Cys/Cys 26 24.1 28 23.1 1.34 (0.65–2.77) 0.427 1.47 (0.69–3.12) 0.313       MUTYH                         LCZ696 order   Gln/Gln 22 20.3 37 30.6 1.00   1.00   Gln 0.468 0.591   Gln/His 57 52.8 69 57.0 1.39 (0.74–2.62) 0.309 1.35 (0.70–2.61) 0.376 His 0.532 0.409   His/His 29 26.9 15 12.4 3.25 (1.44–7.36) 0.005 3.03 (1.31–7.00) 0.010       a: OR adjusted for gender, age, smoking

habit Table 3 summarizes the genotype distribution for lung adenocarcinoma and squamous cell carcinoma, showing the OR adjusted for gender, age, and smoking habits. The crude and adjusted ORs for the OGG1 Ser/Cys or Cys/Cys genotypes compared with the Ser/Ser genotype were not significant for adenocarcinoma and squamous cell carcinoma. The crude ORs for the MUTYH His/His genotype compared with Gln/Gln genotype showed a significant increase for both adenocarcinoma and squamous cell carcinoma (OR 3.04, 95%CI 1.18–7.82, p = 0.021 for adenocarcinoma; OR 4.11, 95%CI 1.27–13.33, p = 0.019, respectively). The adjusted ORs for the ASK1 MUTYH His/His genotype compared with Gln/Gln genotype showed a borderline significant

for adenocarcinoma and squamous cell carcinoma (OR 2.50, 95%CI 0.95–6.62, p = 0.065 for adenocarcinoma; OR 3.20, 95%CI 0.89–11.49, p = 0.075 for squamous cell carcinoma, respectively). While, there was no significant increase for the MUTYH Gln/His genotype in the histological types. Table 3 Genotype distribution in relation to histological type in lung cancer Genotype Adenocarcinoma Squamous Cell Carcinoma   patients (n = 67) controls (n = 121) crude adjusted patients (n = 31) controls (n = 121) crude adjusted   n % n % OR (95%CI)a P-value OR (95%CI)a P-value n % n % OR (95%CI)a P-value OR (95%CI)a P-value OGG1                                 Ser/Ser 17 25.4 39 32.2 1.00   1.00   8 25.8 39 32.3 1.00   1.00   Ser/Cys 33 49.2 54 44.6 1.40 (0.69–2.87) 0.355 1.34 (0.64–2.81) 0.439 16 51.6 54 44.6 1.44 (0.56–3.71) 0.445 1.23 (0.44–3.43) 0.695 Cys/Cys 17 25.4 28 23.1 1.39 (0.61–3.19) 0.434 1.31 (0.56–3.08) 0.530 7 22.6 28 23.1 1.22 (0.40–3.75) 0.730 1.54 (0.45–5.

05 respectively)(Table 2) Table 2 Association of Lamin A/C immun

05 respectively)(Table 2). Table 2 Association of Lamin A/C immunostaining with clinicopathological parameters in 126 cases of primary GC Clinicopathological variable Cases (n = 126) Lamin A/C p -value     positive (%) negative (%)       n = 70 n = 56   Gender       0.410    male 88 51 (58.0) 37 (42.0)      female 38 19 (50.0) 19 (50.0)   Age (years) a       0.905    < 56 60 33 (55.0) 27 (45.0)      ≥ 56 66 37 (56.1) 29 (43.9)   Tumour size

(cm) a       0.902    < 5 78 43 (55.1) 35 (44.9)      ≥ 5 48 27 (56.3) 21 (43.7)   Depth of invasion       0.870    T1 9 6 (66.7) 3 (33.3)      T2 22 12 (54.5) 10 (45.5)      T3 75 42(56.0) 33 (44.0)      T4 20 10 (50.0) 10 (50.0)   Lymph node metastasis b       0.550    N0 42 23 (54.8) 19 (45.2)      N1 36 22 (61.1) 14 (38.9)      N2 38 18 (47.4) 20(52.6)      N3 10 7(70.0) 3 (30.0)   Distant metastasis       0.659    M0 101 55 (54.5) 40 (45.5)      M1 25 15(60.0) 10 (40.0)   Staging       0.894    I 17 10 (58.8) 7 (41.2)      II 27 14 (51.9) 13 (48.1)      III 47 25 (53.2) 22 (46.8)      IV 35 21 (60.0) 14 (40.0)   Differentiation       0.034c    well 19 15(78.9) 4 (21.1)      moderate 20

13(65.0) 7 (35.0)      poor 67 35(51.6) 32 (48.4)      undifferentiated 20 7 (35.0) 13 (65.0)   agrouping of age and tumour size was performed according to median. b grouping of staging and selleck kinase inhibitor lymph node metastasis was performed according to UICC classification (TNM 1997). cstatistical 4SC-202 solubility dmso significance Montelukast Sodium (p < 0.05) Figure 4 Immunohistochemical detection of Lamin A/C protein expression in

GC and surrouding non-cancerous tissues. Positive staining was mostly seen on nuclear of epithelial cells. (A) positive staining of Lamin A/C in normal gastric mucosa(× 100). (B) negative staining of Lamin A/C in well-differentiated gastric carcinoma(× 100). (C) negative staining of Lamin A/C in moderately differentiated gastric carcinoma(× 100). (D) negative staining of Lamin A/C in gastric signet-ring cell carcinoma(× 100). T, GC; N, corresponding non-cancerous tissues. The right upper frame of each figure showing high-power field(× 400). Correlation between lamin A/C expression and patients’ survival Using Kaplan-Meier curve method, we evaluated the relationship between the lamin A/C expression and the outcome of 126 patients. The overall survival rates were 58.6% and 44.6%, respectively, in patients with positive and negative lamin A/C expression. Of 70 lamin A/C immunohistochemical positive-staining patients, the median survival time is 45.0 ± 5.5 months, while that of 56 negative-staining patients is 26.0 ± 4.2 months. There was a significantly longer median survival time in the lamin A/C protein-positive group than in the negative group (P = 0.034, log-rank test; Fig. 5).

Anesth Prog 1991;38:128–41 PubMed 11 Kahokehr A, Sammour T, Vat

Anesth Prog. 1991;38:128–41.PubMed 11. Kahokehr A, Sammour T, Vather R, Taylor M, Stapelberg F, Hill AG. Systemic levels of local anaesthetic after intra-peritoneal application–a systematic review. Anaesth Intensive Care. 2010;38(4):623–38.PubMed 12. Benowitz NL, Meister W. Clinical Akt inhibitor pharmacokinetics of lignocaine. Clin Pharmacokinet. 1978;3:177–201. 13. Oral E, Olive DL, Arici A. The peritoneal environment in endometriosis. Hum Reprod Update. 1996;2(5):385–98.PubMedCrossRef 14. DiZerega GS, Rodgers KE. The peritoneum. New York: Springer; 1992. 15. Koninckx PR,

Kennedy SH, Barlow DH. Endometriotic disease: the role of peritoneal fluid. Hum Reprod Update. 1998;4(5):741–51.PubMedCrossRef 16. Narchi P, Benhamou D, Bouaziz H, Fernandez H, Mazoit JX. Serum concentrations of local anaesthetics following intraperitoneal ARN-509 price administration during laparoscopy. Eur J Clin Pharmacol. 1992;42:223–5.PubMedCrossRef 17. Wickström K, Bruse C, Sjösten A, Spira J, Edelstam G. Pertubation with lignocaine as a new treatment of dysmenorrhea due to endometriosis: a randomized controlled trial. Hum Reprod. 2012;27(3):695–701.PubMedCrossRef 18. Masse RI, Dunbar RW. Plasma lidocaine concentrations after caudal, lumbar, epidural, axillary block, and intravenous regional anesthesia. Anesthesiology. 1966;27(3):574–9.”
“1 Introduction

Acute myocardial infarction (AMI) CRT0066101 triggers an ischemic state in the myocardium, after which a process of remodeling is initiated by gradual myocardial ventricular dilation, hypertrophy, and distortion of left ventricular (LV) geometry [1]. The remodeling process, which can be categorized into the two phases of early (≤72 h) and late (>72 h) [2], is considered to be a determinant of mortality and morbidity in patients after AMI [3]. Several mechanisms contribute to the remodeling process, including myocardial cell death, fibrotic changes in cardiomyocytes following collagen synthesis, and inflammation due to increased

expression of pro-inflammatory cytokines [4–6]. Ischemia following AMI provoked an increase in the level of main pro-fibrotic cytokine, transforming growth factor (TGF)-β, which induces fibrotic depositions in the cardiomyocytes [7]. TGF-β plays a significant role in the pathogenesis of the remodeling process, as its inhibition in the proliferative Resveratrol phase of remodeling can prevent the LV from hypertrophy and decrease the extent of fibrosis in the non-infarcted segments of the myocardium and improve LV geometry [8, 9]. On the other hand, AMI is associated with acute up-regulation of pro-inflammatory cytokines, with tumor necrosis factor (TNF)-α being the most important [10]. TNF-α stimulated the remodeling process and provoked myocardial dysfunction after AMI [11–13]. Moreover, TNF-α can increase the expression of angiotensin receptor in the cardiac fibroblasts of animal models, which increased the activity of angiotensin and therefore induced fibrotic changes [14].

For qPCR the cDNA template was used in a reaction mixture contain

For qPCR the cDNA template was used in a reaction mixture containing SYBR green with ROX as a reference dye (SYBR green 2x Master mix) (BioGene, UK) and gene-specific forward and reverse primers (Table 4). Reactions were performed using an ABI 7000 machine (Applied

Biosystems, UK). qPCR amplification was performed using gene-specific primers with product sizes of approximately 150 bp. The reaction conditions for the qPCR were as follows: 95 °C for 10 minutes for the polymerase activation step, 40 cycles each of denaturing at 95 °C for 15 seconds, and annealing-extension at 60 °C for 15 seconds. To confirm primer specificity, melting curve analysis was performed with the following conditions; 95 °C for 15 seconds, 60 for 1 seconds, and 60 to 95 °C with a ramping rate of 0.5 °C per 10 seconds. Table 4 Oligonucleotide primers used in qRT-PCR with B. fragilis and B. thetaiotaomicron


interest were normalized. Fold changes in gene expression were calculated by standard formula 2(En-Et)-(Rn-Rt), where En is the cycle threshold (Ct) of the experimental gene (e.g. bfp1) in the control sample, Rn is the Ct of the reference gene (i.e. 16S rRNA) in the control sample, Et is the Ct of the experimental gene in the test sample and Rt is the Ct of the reference gene in the test sample [53]. qPCR was repeated on two different biological replicates and three technical replicates. Results were expressed as n-fold increase or decrease of expression upon exposure to different growth conditions, with a value of 1 representing no change in expression between the test and control samples. Growth of B.

Strain Description Reference MG1655 wild type Coli Genetic Stock

Table 5 List of strains used. Strain Description Reference MG1655 wild type Coli Genetic Stock Center MG1655 ΔarcA ArcA knockout strain This study MG1655 ΔiclR MDV3100 price IclR knockout strain This study MG1655 ΔarcAΔiclR ArcA-IclR double knockout strain This study BL21 (DE3) wild type Coli Genetic Stock Center Media Luria Broth (LB) medium consisted of 10 g.L -1 tryptone peptone (Difco, Belgium), 5 g.L -1 yeast extract (Difco) and 10 g.L -1 sodium chloride. Shake flask medium (S) contained 2 g.L -1 NH4Cl, 5 g.L -1 (NH4)2SO4, 2.993 g.L -1 KH2PO4, 7.315 g.L -1 K2HPO4, 8.372 g. L -1 MOPS, 0.5 g. L -1 NaCl, 0.5 g.L -1 MgSO4 · 7 H2O, 16.5 g.L -1 glucose · H2O, 1 mL.L -1 trace element solution and 100

μL.L -1 molybdate solution. The medium was set to a pH of 7 with 1 M KH2PO4. The minimal medium during fermentations (M1) in a benchtop bioreactor contained 6.75 g.L -1 NH4Cl, 1.25 g.L -1 (NH4)2SO4, 1.15 g.L -1 KH2PO4, 0.5 g.L -1 NaCl, 0.5 g.L -1 MgSO4

· 7 H2O, 16.5 g.L -1 glucose · H2O, 1 mL.L -1 trace element solution and 100 μL.L -1 molybdate solution. In 13C-flux analysis experiments, minimal medium for minireactors (M2) was used. This medium contained 1 g.L ZD1839 -1 NH4Cl, 1 g.L -1 (NH4)2SO4, 3 g.L -1 KH2PO4, 7.315 g.L -1 Na2HPO4, 0.5 g.L -1 NaCl, 0.5 g.L -1 MgSO4 · 7 H2O, 3 g.L -1 glucose, 1 mL.L -1 trace element solution, 100 μL.L -1 molybdate solution. The glucose used in this M2 medium was added as a mixture of 20% U-13C glucose (99% purity) and 80%

naturally labeled glucose or as a mixture of 50% 1-13C glucose (99% purity) and 50% naturally labeled glucose depending on the flux ratios that needed to be identified. Trace element solution consisted of 3.6 g.L -1 FeCl2 · 4 H2O, 5 g.L -1 CaCl2 · 2 H2O, 1.3 g.L -1 MnCl2 · 2 H2O, 0.38 g.L -1 CuCl2 · 2 H2O, 0.5 g.L -1 CoCl2 · 6 H2O, 0.94 g.L -1 ZnCl2, 0.0311 g.L -1 H3BO4, 0.4 g.L -1 Na2EDTA · 2 H2O, 42 g.L -1SeO2 and 1.01 g.L -1 thiamine · HCl. The molybdate solution contained 0.967 g.L -1 Na2MoO4 · 2 H2O. If not specifically mentioned, all chemicals were Cell press purchased at Sigma, Belgium. Cultivation conditions To determine substrate uptake and product secretion rates, enzyme activities, and glycogen and trehalose contents, cells were cultivated in 2L benchtop JNK inhibitor bioreactors, since higher volume vessels improve accuracy of the measurements. However, in order to map the metabolic fluxes in the cell, expensive 13C-labeled substrates are necessary and therefore alternative miniscale reactors were chosen as the method of cultivation. Earlier studies have shown that similar growth conditions were achieved in the benchtop and miniscale reactor setups [69, 70]. For experiments in bioreactors, a preculture in a test tube filled with 5 mL LB medium was inoculated with a single colony from a LB-plate and incubated during 8 hours at 37°C on an orbital shaker at 200 rpm.

The running time to exhaustion correlated significantly with the

The running time to exhaustion correlated significantly with the soleus (r=0.65, p > 0.002) and gastrocnemius (r = 0.60, p > 0.004) glycogen content. Discussion Despite cassava having a high carbohydrate content and potential benefit for sports performance, no study has investigated the effects of cassava on sports performance. As a result, this is the first study

to examine the extracted polysaccharides from sweet cassava on sports performance in rats, to our knowledge. The literature shows that muscle glycogen content is associated with running time to exhaustion in both human [16, RG7420 17] and animal studies [18]. In addition, fatigue or a decline in sports performance is attributable to reduced muscle glycogen content [19, 20]. As a result, increased muscle glycogen delays fatigue and/or extends the time to exhaustion. In this study,

although muscle glycogen content in the soleus and gastrocnemius muscle learn more was lower in the ExSCP and Ex groups compared to the C group after exhaustive exercise, the glycogen content in the two muscle types of the ExSCP group were significantly higher than that of the Ex group. This indicates that SCP Dorsomorphin nmr supplementation may boost muscle glycogen. In addition, the ExSCP group had a longer running time to exhaustion compared to the Ex group, and the running time to exhaustion was also significantly related to muscle glycogen (r = 0.65 and 0.60 for the soleus and gastrocnemius muscles, respectively). Although these preliminary results were similar to those of the study by Bergstrom et al. [21], these findings should be interpreted cautiously, especially the causation between muscle glycogen and exhaustive performance, because this study did not measure the difference in muscle glycogen content between pre- and post-exhaustive PR 171 exercise and we did not know how much muscle glycogen was metabolized during the exhaustive running. Further studies are necessary to address this issue. Increasing muscle glycogen through diet, and before exercise, is one method

of enhancing endurance capacity. Many researchers have tried to find new substances or regimes to elevate muscle glycogen in order to boost sports performance. Although some studies reported that sweet cassava has abundant carbohydrates, such as monosaccharides [2, 3] and polysaccharides [4], little is known about whether there is any beneficial influence of sweet cassava on sports performance. In addition, several studies reported that supplementation with extracted polysaccharides is beneficial for increasing glycogen levels and extending the running time to exhaustion [10–12]. The effect of extracted polysaccharides from sweet cassava on boosting sports performance was similar to that seen in the above-mentioned studies and was proven in this study. However, we cannot explain why the glycogen levels of the gastrocnemius muscles were different from those of the soleus muscles in the three groups.

Differentially expressed protein spots between the two groups wer

Differentially expressed protein spots between the two groups were calculated using the Student-T test with a critical p-value

≤ 0.05 and the permutation-based method to avoid biased results that may arise within replicate gels if spot quantities are not normally distributed. The adjusted Bonferroni correction was applied for false discovery rate (FDR) to control the proportion of false positives in the buy Tozasertib result set. Principal component analysis was performed to determine samples/spots that contributed most to the variance and their relatedness. Differentially expressed protein spots of interest were manually excised and each placed into separate microcentrifuge tubes. Gel pieces were rinsed briefly with 100 μl of 25 mM NH4HCO3, incubated in 100 μl of 25 mM NH4HCO3 in 50% (v/v) acetonitrile (ACN) for 30 min with gentle shaking, dehydrated with 100 μl of 100% (v/v) ACN for 10 min and then rehydrated with 100 μl of 25 mM NH4HCO3 for 30 min with gentle shaking. Gel pieces were dehydrated again with 100 μl of 100% (v/v) ACN for 10 min and completely evaporated.

Proteins were reduced with 50 μl of 10 mM DTT in 100 mM NH4HCO3 at 56°C for 45 min and then alkylated with 50 μl of 50 mM iodoacetamide in 100 mM NH4HCO3 for 30 min at room temperature in the dark. Gel pieces were rinsed with 200 μl of 100 mM NH4HCO3 check details and then with 200 μl of 100% (v/v) ACN for 10 min each step. These steps were repeated once more. Gel pieces were completely dehydrated and incubated with 200 ng of trypsin (Worthington Biochemical Corp., Lakewood, NJ) diluted in 50 mM NH4HCO3 overnight at 30°C. Samples were cooled down to room temperature and incubated with 20 μl of 20 mM NH4HCO3 for 10 min. Peptides were extracted twice from the gel pieces with 20 μl of 5% (v/v) formic acid (FA) in 50% (v/v) ACN for 10 min each, collected to separate tubes, evaporated and stored at −20°C prior to mass spectrometry analysis. Digested peptide mixtures were suspended in 0.1% (v/v) formic acid (FA) in 5% (v/v) ACN, and analyzed with an LTQ Orbitrap

mass spectrometer (Thermo Scientific, Bremen, Germany) equipped with an electrospray ion source and coupled to an AZD1480 ic50 EASY-nanoLC (Proxeon Biosystems, oxyclozanide Odense, Denmark) for nano-LC-MS/MS analyses. A volume of 5 μl of the peptide mixture was injected onto a 5 μm, 300 Å, 50 mm long × 0.3 mm Magic C18AQ (Michrom, Thermo-Scientific) pre-column and a 3 μm, 100 Å, 100 mm long × 0.1 mm Magic C18AQ (Michrom, Thermo-Scientific) column. A spray voltage of 1,500 V was applied. The mobile phases consisted of 0.1% FA and 5% ACN (A) and 0.1% FA and 90% ACN (B). A three step gradient of 0-40% B in 20 min, then 40-90% B in 5 min and finally 90% B for 20 min with a flow of 500 nl/min over 45 min was applied for peptide elution. The MS scan range was m/z 350 to 1,600.

In hemodynamically stable

In hemodynamically stable patients with penetrating left thoracoabdominal trauma, the incidence of injury to the diaphragm is very high, and thoracoscopy or laparoscopy is recommended for the diagnosis and repair of a missed diaphragmatic injury. Laparoscopy or video-assisted thoracoscopic surgery (VATS) can be used in hemodynamically stable patients. VATS has greater accuracy (sensitivity and specificity close to 100%) and helps to avoid the risk of tension pneumothorax

[19]. However, we feel that VATS is best reserved for stable patients when intraabdominal and contralateral diaphragmatic injuries are excluded. Grimes, in 1974, described the three phases of the rupture of the diaphragm: an initial acute phase, at the time of the injury to the diaphragm; [17] a delayed phase associated with transient herniation of the viscera, thus accounting for absent or intermittent non-specific symptoms; and the obstruction phase involving the PD-1 assay complication of a long-standing herniation, manifesting as obstruction, LY2835219 concentration strangulation and posterior rupture [18]. The typical organs that herniate into the thoracic cavity include the stomach,

spleen, colon, small bowel and liver, Repair with non-absorbable simple sutures is adequate in most cases, and the use of mesh should be reserved for chronic and large defects. Thus, all surgeons must be vigilant during any exploratory laparotomy to exclude any associated diaphragmatic injury. Mortality strictly related to diaphragmatic rupture is minimal, and is usually caused by the associated injuries. The most common causes of death C-X-C chemokine receptor type 7 (CXCR-7) reported in the literature are shock, multiple organ failure and head injuries [9]. Outcomes of acute diaphragmatic hernia repair are

largely dictated by the severity of concomitant injuries, with the Injury Severity Score being the most widely recognised predictor of mortality. Delayed diagnosis may increase mortality by up to 30% [8]. The rate of initially missed diaphragmatic ruptures or injuries in nonoperatively managed patients, therefore, ranges from 12 to 60% [3]. Blunt diafragmatic rupture can easily be missed in the absence of other indications for prompt surgery, where a thorough examination of both hemidiaphragms is mandatory. A high index of suspicion combined with repeated and selective radiologic evaluation is necessary for early diagnosis. Acute diaphragmatic hernia is a result of diaphragmatic injury that accompanies severe blunt or penetrating thoracoabdominal trauma. It is Hedgehog inhibitor frequently diagnosed early on the trauma by chest radiograph or CT scan of the chest. Non-adverted diaphragmatic injury resulting from the chronic phase of a diaphragmatic hernia will probably require surgery to repair the defect. Conclusions Blunt diaphragmatic rupture can lead to important morbidity and mortality. It is a rare condition, usually masked by multiple associated injuries, which can aggravate the condition of patients.

Nat Med 2007, 13: 286–287 PubMedCrossRef 52 McKean SC, Davies JK

Nat Med 2007, 13: 286–287.PubMedCrossRef 52. McKean SC, Davies JK, Moore RJ: Expression of phospholipase D the major virulence factor of Corynebacterium pseudotuberculosis , is regulated by multiple environmental factors and plays a role in macrophage death. Microbiology 2007, 153: 2203–2211.PubMedCrossRef 53. Hodgson AL, Krywult J, Corner LA, Rothel JS, Radford AJ: Rational attenuation of Corynebacterium pseudotuberculosis : potential cheesy gland vaccine and live delivery vehicle. Infect Immun 1992, 60: 2900–2905.PubMed 54. McNamara PJ, Bradley

GA, Songer JG: Targeted mutagenesis of the phospholipase D gene results in decreased virulence of Corynebacterium pseudotuberculosis . Mol Microbiol 1994, DAPT mouse 12: 921–930.PubMedCrossRef 55. Moore RJ, PRIMA-1MET purchase Rothel L, Krywult J, Radford AJ, Lund K, Hodgson AL: Foreign gene expression in Corynebacterium pseudotuberculosis : development of a live vaccine vector. Vaccine 1999, 18: 487–497.PubMedCrossRef 56. Meyer R, Carminati R, Bahia R, Vale V, Viegas S, Martinez T, Nascimento I, Schaer R, Silva J, Ribeiro M, Regis L, Paule B, Freire S: Evaluation of the goats humoral immune response induced by the Corynebacterium pseudotuberculosis

lyophilized live vaccine. J Med Biol Sci 2002, 1: 42–48. 57. Walker J, Jackson HJ, Eggleton DG, Meeusen EN, Wilson MJ, Brandon MR: Identification of a novel antigen from Corynebacterium pseudotuberculosis that protects sheep against caseous EX 527 research buy lymphadenitis. Infect Immun 1994, 62: 2562–2567.PubMed 58. Koonin EV, Makarova KS, Aravind L: Horizontal gene transfer in prokaryotes:

quantification and classification. Annu Rev Microbiol 2001, 55: 709–742.PubMedCrossRef out 59. Nogueira T, Rankin DJ, Touchon M, Taddei F, Brown SP, Rocha EPC: Horizontal gene transfer of the secretome drives the evolution of bacterial cooperation and virulence. Curr Biol 2009, 19: 1683–1691.PubMedCrossRef 60. Hett EC, Rubin EJ: Bacterial growth and cell division: a mycobacterial perspective. Microbiol Mol Biol Rev 2008, 72: 126–56. table of contentsPubMedCrossRef 61. Allen CE, Schmitt MP: HtaA is an iron-regulated hemin binding protein involved in the utilization of heme iron in Corynebacterium diphtheriae . J Bacteriol 2009, 191: 2638–2648.PubMedCrossRef 62. Puech V, Chami M, Lemassu A, Lanéelle MA, Schiffler B, Gounon P, Bayan N, Benz R, Daffé M: Structure of the cell envelope of corynebacteria: importance of the non-covalently bound lipids in the formation of the cell wall permeability barrier and fracture plane. Microbiology 2001, 147: 1365–1382.PubMed 63. Jordan S, Hutchings MI, Mascher T: Cell envelope stress response in Gram-positive bacteria. FEMS Microbiol Rev 2008, 32: 107–146.PubMedCrossRef 64. Hansmeier N, Chao T, Daschkey S, Müsken M, Kalinowski J, Pühler A, Tauch A: A comprehensive proteome map of the lipid-requiring nosocomial pathogen Corynebacterium jeikeium K411. Proteomics 2007, 7: 1076–1096.PubMedCrossRef 65.

Washington: American Society for Microbiology; 1994 11 Bagchi K

Washington: American Society for Microbiology; 1994. 11. Bagchi K, Echeverria P, Arthur JD, Sethabutr O, Serichantalergs O, Hoge CW: Epidemic of diarrhea caused by Vibrio cholerae non-O1 that produced heat-stable toxin among Khmers in a camp in Thailand. J Clin Microbiol 1993, 31:1315–1317.PubMed 12. Ramamurthy T, Bag PK, Pal A, Bhattacharya SK, Bhattacharya MK, Shimada T, Takeda T, Karasawa T, Kurazono H, Takeda

Y: Virulence Seliciclib patterns of Vibrio cholerae non-O1 strains isolated from hospitalised patients with acute diarrhoea in Calcutta, India. J Med Microbiol 1993, 39:310–317.PubMedCrossRef 13. Rudra S, Mahajan R, Mathur M, Kathuria K, Talwar V: Cluster of cases of clinical cholera due to Vibrio cholerae O10 in east Delhi. Indian J Med Res 1996, 103:71–73.PubMed 14. Sharma C, Thungapathra M, Ghosh A, Mukhopadhyay AK, Basu A, Mitra R, Basu I, Bhattacharya SK, Shimada T, Ramamurthy T: Molecular analysis of non-O1, RG-7388 chemical structure non-O139 Vibrio cholerae associated with an unusual upsurge in the incidence of cholera-like disease in Calcutta, India. J Clin Microbiol 1998, 36:756–763.PubMed 15. Bhattacharya MK, Dutta D, Bhattacharya SK, Deb A, Mukhopadhyay AK, Nair GB, Shimada T, Takeda Y, Chowdhury A, Mahalanabis D: Association of a disease approximating cholera caused by Vibrio cholerae of serogroups other than O1 and O139. Epidemiol Infect 1998, 120:1–5.PubMedCrossRef

16. Chatterjee S, Ghosh K, Raychoudhuri A, Chowdhury G, Bhattacharya MK, Mukhopadhyay MK5108 AK, Ramamurthy T, Bhattacharya SK, Klose KE, Nandy RK: Incidence, virulence factors, and clonality among clinical strains of non-O1, non-O139

Vibrio cholerae isolates from hospitalized diarrheal Endonuclease patients in Kolkata, India. J Clin Microbiol 2009, 47:1087–1095.PubMedCrossRef 17. Teh CS, Chua KH, Thong KL: Genetic variation analysis of Vibrio cholerae using multilocus sequencing typing and multi-virulence locus sequencing typing. Infect Genet Evol 2011, 11:1121–1128.PubMedCrossRef 18. Rivera IN, Chun J, Huq A, Sack RB, Colwell RR: Genotypes associated with virulence in environmental isolates of Vibrio cholerae . Appl Environ Microbiol 2001, 67:2421–2429.PubMedCrossRef 19. Singh DV, Matte MH, Matte GR, Jiang S, Sabeena F, Shukla BN, Sanyal SC, Huq A, Colwell RR: Molecular analysis of Vibrio cholerae O1, O139, non-O1, and non-O139 strains: clonal relationships between clinical and environmental isolates. Appl Environ Microbiol 2001, 67:910–921.PubMedCrossRef 20. Faruque SM, Mekalanos JJ: Pathogenicity islands and phages in Vibrio cholerae evolution. Trends Microbiol 2003, 11:505–510.PubMedCrossRef 21. Faruque SM, Naser IB, Islam MJ, Faruque AS, Ghosh AN, Nair GB, Sack DA, Mekalanos JJ: Seasonal epidemics of cholera inversely correlate with the prevalence of environmental cholera phages. Proc Natl Acad Sci USA 2005, 102:1702–1707.PubMedCrossRef 22.